Keyphrases
Infective Endocarditis
100%
Endocarditis
81%
Heart Failure
59%
Systolic Heart Failure
49%
Oral Antibiotics
43%
Plasma Concentration
37%
Renal Disease
36%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
35%
Copenhagen
34%
Heart Failure Risk
33%
Risk Study
33%
Confidence Interval
32%
All-cause Mortality
31%
Bacteremia
27%
Oral Treatment
27%
Left-sided Infective Endocarditis
22%
Cardiovascular Biomarkers
22%
Renal Impairment
22%
Fascia Dentata
22%
Hippocampal Lesion
22%
Left-handed
22%
Natriuretic Peptides
22%
Hospitalized COVID-19 Patients
22%
Excitotoxic
22%
Enterococcus Faecalis
21%
Renal Function
18%
Echocardiography
17%
Intravenous Antibiotic Treatment
17%
Treatment Trials
16%
Atrial Natriuretic Peptide
16%
Echocardiographic
16%
Linezolid
15%
Rifampicin
15%
Global Longitudinal Strain
15%
Antibiotic Treatment
15%
Myocardial Function
14%
Patients with Heart Failure
14%
Left Ventricular Ejection Fraction
14%
Hippocampus
13%
Adult Rats
13%
Echocardiographic Parameters
13%
High Risk
13%
Cardiac Biomarkers
13%
Probability of Target Attainment
13%
Hazard Ratio
13%
Cardiac Function
13%
E. Faecalis
12%
Cardiac Surgery
12%
Antibiotics
12%
Moderate to Severe
12%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
79%
Bacterial Endocarditis
77%
Endocarditis
62%
Systolic Heart Failure
59%
Biological Marker
43%
Antibiotics
33%
Prevalence
29%
All Cause Mortality
25%
Bacteremia
25%
Brain Natriuretic Peptide
24%
Natriuretic Factor
22%
Enterococcus faecalis
19%
Atrial Natriuretic Factor
18%
Linezolid
15%
Rifampicin
15%
Streptococcus
15%
Antibiotic Agent
13%
Pharmacodynamics
13%
Pharmacokinetics
12%
Gram Positive Cocci
11%
Aldosterone
11%
End Stage Renal Disease
11%
Methylphenidate
11%
Cause of Death
11%
Diabetes Mellitus
11%
Iron Deficiency
11%
Infarction
11%
Thromboembolism
11%
Anemia
11%
Vasopressin
11%
Biomarker Study
11%
Heart Infarction
11%
Mirabegron
11%
Clinical Trial
11%
Cyclic GMP
11%
Adrenergic Receptor
11%
Acute Heart Infarction
11%
Galectin 3
11%
Pharmacokinetics
11%
Penicillin G
11%
Copeptin
10%
Disease
8%
Troponin
8%
C Reactive Protein
8%
Chronic Kidney Failure
7%
Heart Failure with Reduced Ejection Fraction
6%
Staphylococcus Aureus
5%
Disease Severity
5%
Attention Deficit Disorder
5%
Placebo
5%
Medicine and Dentistry
Outpatient
57%
Heart Failure
53%
Systolic Heart Failure
48%
Infective Endocarditis
36%
Congestive Heart Failure
33%
Endocarditis
32%
Biological Marker
26%
Prevalence
23%
Antibiotic Therapy
22%
Fascia Dentata
22%
Heart Function
22%
Transplantation
22%
Cardiovascular System
22%
Antibiotics
18%
New York Heart Association Class
18%
Heart Surgery
12%
Symptomatic Treatment
12%
Heart Left Ventricle Ejection Fraction
12%
Vasopressin
11%
Ischemia
11%
Adrenergic Receptor
11%
Lung Transplantation
11%
Fluorodeoxyglucose
11%
Heart Transplantation
11%
Aldosterone
11%
Pulmonary Artery
11%
Vertebral Artery Dissection
11%
Genetic Variability
11%
Nerve Cell Degeneration
11%
Eisenmenger's Syndrome
11%
Calcium Metabolism
11%
Cyclic GMP
11%
Coronary Artery Disease
11%
Polymerase Chain Reaction
11%
HERG
11%
Potassium Ion
11%
COVID-19
11%
Revascularization
11%
Onset Age
11%
Clinical Trial
11%
Positron Emission Tomography-Computed Tomography
11%
Mirabegron
11%
Population Risk
11%
Hemodynamic
11%
End Stage Renal Disease
11%
Biomarker Study
11%
Sudden Infant Death Syndrome
11%
Mitral Insufficiency
11%
Iron Deficiency
11%
Long QT Syndrome
11%
